Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma
Immune checkpoint inhibitors in sarcomas: a systematic review 13569.rar
Research into PRAME as an immunotherapy target in sarcoma subtypes. Genomic alterations and clinical outcomes in patients with
This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors. likely part of the dataset
Studies on how combinations of drugs (like TKIs and anti-CTLA-4) treat sarcoma, particularly Alveolar Soft Part Sarcoma.
Analysis of DNA methylation patterns affecting chemo-resistance in sarcoma patients.
Other related research topics often found in similar databases include: